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Abstract Linkage analysis is described in a family with 
X-linked m ental retardation, ataxia, weakness, floppiness, 
delayed m otor developm ent, absence o f deep tendon re­
flexes, hearing im pairm ent and loss of vision (M IM  no. 
301835). The disease has a fatal course due to the suscep­
tibility of the patients to infections, especially of the res­
piratory tract. Clinical signs indicate impairment of the 
posterior columns, peripheral m otor and sensory neurons 
and the second and eighth cranial nerves and/or their nu ­
clei. The involvem ent o f the posterior columns of the 
spinal cord is further suggested by the almost complete 
absence of myelinated fibers therein. We localized the re­
sponsible gene(s) to X q2 1 .3 3 -q 2 4  betw een D X S 1231 and 
DXS 1001 with a m axim um  lod score o f  6.97. The prote- 
olipid protein gene, which codes for two myelin proteins 
of the central nervous system  and is located in this region, 
was considered as a  candidate gene for this disorder. 
However, no m utations w ere found in the protein-coding 
part of this gene.
Introduction
X-linked syndromes with m ental retardation form part of 
the m ore than 120 different X -linked mental retardation 
conditions described so far (for review  see Arena and 
Lubs 1991; Glass 1991; Neri 1994). The majority o f  the 
syndromic forms o f  X -linked m ental retardation have 
been assigned to specific regions o f the X chrom osom e by 
cytogenetic studies and linkage analysis (Neri 1994). A 
number o f them have been show n to be m onogenic and
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the gene involved has been identified, i.e., the fragile-X 
syndrom e (Verkerk et al. 1991), Norrie disease (Berger 
et al. 1992; Chen et al. 1992), adrenoleukodystrophy 
(M osser et aL 1993), Menkes disease (Chelly et al. 1993; 
M ercer et al. 1993; Vulpe et al. 1993), and DMD (Monaco 
et al. 1986). Recently, the gene coding for monoamine ox­
idase type A  has been identified as the cause of mental 
im pairm ent with behavioral disturbance (Brunner et al. 
1993). O ther syndromes might be contiguous gene syn­
drom es.
W e perfo rm ed  linkage analysis in a family with a 
syndrom ic  developm ental delay, previously described 
by  Arts et al. (1993; M IM  no. 301835, Fig. 1). Patients 
show  a com bination  o f a num ber o f the following sym p­
tom s: m en ta l retardation, an early onset floppiness, 
w eakness , ataxia, deafness, delayed m otor development, 
nystagm us, loss o f vision and susceptibility to infec­
tions, especia lly  of the respiratory tract. Flaccid tetraple­
g ia  and  areflex ia  appear later. Infections were the cause 
o f  death  befo re  the age o f  6 years in 11 o f  12 boys. The 
o ldest pa tien t, now 16 years o f age, has become nearly 
b lind  ow in g  to optic atrophy and lives in an institute for 
the  v isua lly  and m entally handicapped. Clinical signs in­
d ica te  im pairm ent o f the posterior columns, peripheral 
m o to r  and sensory neurons and the second and eighth 
cran ia l nerves and/or nuclei. The central nervous system 
(C N S) o f one  patient could be exam ined at autopsy. In 
the  poste rio r columns o f  the spinal cord, myelin was 
found  to b e  alm ost com pletely  absent whereas no abnor­
m alities  w ere  seen in the brainstem  and in the gray and 
w hite  m a tte r  o f the cerebral and cerebellar hemispheres. 
A  num ber o f  dorsal nerve roots that could be exam ined 
sh o w e d  the  sam e abnorm alities as the posterior 
co lum ns. B iochem ical or im m unological defects could 
n o t be  de tec ted  in patients. Carriers may suffer from per­
cep tive  hearing  loss, ataxic diplegia, extensor plantar re­
flexes, hypoton ia , hyperreflexia or low deep tendon re­
flexes.
L inkage analysis has enabled us to assign regionally 
the  gene(s) responsible for this condition to Xq21,33-q24, 
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Analysis of DNA markers
For the typing of the DNA markers, genomic DNA was isolated 
from peripheral blood according to the method of Miller et al.
(1988). Fifty nanograms of genomic DNA was amplified in a 15 Jil 
reaction mixture containing 1 x Supertaq buffer [10 mM TRIS- 
HC1, pH 9.0, 50 mM KC1, 1.5 mM MgCU, 0.1% Triton X-100, 
0.01% (w/v) gelatin], 200 jiM each of dATP, dGTP, dTTP and 
2.5 jiM dCTP, 0.6 (iCi [ a 32P]dCTP (10 mCi/ml, 3000 Ci/mmol), 
and 0.06 U Supertaq (HT Biotechnology, England). The initial de- 
naturation of 5 min at 94° C was followed by 35 cycles of 94° C for
1 min* 55° C for 2 min and 72° C for 3 min. After the cycles there 
was a final extension of 6 min at 72°C (method modified from 
Weber and May 1989). Amplification was performed in a 96-well 
thermal cycler (M. J. Research). Samples were analyzed on a 6 .6% 
polyacrylamide gel (19:1 acrylamiderN^N'-methylene bisacry- 
lamide) containing 8.3 M urea, 1 x TBE (100 mM TRIS-borate,
2 mM EDTA, pH 8.3) at 60 W for 3-4 h. The gels were dried and 
bands were visualized by overnight exposure on Kodak X-OMAT
S film.
Sequence analysis
Amplification of the exons of the proteolipid protein (PLP) gene 
by the polymerase chain reaction was peiformed as described by 
Gencic et al. (1989). Fragments were cycle sequenced and ana­
lyzed on an ABI 373 automatic sequencer, according to the proto­
col of the manufacturer (ABI, Forster City, USA).
Statistical analyses
Linkage data were evaluated with the subroutine Mlink of the 
Linkage program (version 5.1; Lathrop and Lalouel 1984). Com­
plete penetrance and a frequency of 0.00001 for the disease allele 
were assumed for the calculations. The locations of the markers, 
their genetic distances and allelic frequencies were used as given 
by Nelson et al. (1995) and the Genome Data Base.
Results and discussion
The family with an X-linked mental retardation syndrome 
(Arts et al. 1993) was analyzed for cosegregation with a 
set o f highly polymorphic markers from loci distributed 
along the entire X chromosome. The results of two-point 
linkage analysis are summarized in Table 1.
No recombination was found for the marker loci distal 
to DXS1231 and proximal to DXS1001 (Fig, 1, Table 1) 
with a maximal lod score o f 6 .9 7 , 0milx = 0.00 for the 
marker DXS1106. There was no indication for linkage 
with markers from other parts o f the X chromosome. 
Thus, the X-linked mental retardation gene (or genes) re­
sponsible for the disease in the present family can be as­
signed to the X q21.33-q24 interval between DXS1231 
and DXS1001, which has an estimated length of about 20 
Mb (Nelson et al. 1995).
The PLP gene, which encodes two major components 
of the CNS myelin, PLP and DM 20 (Nave et al. 1987), is 
located in Xq22.1 (Mattei et al. 1986), and is thus within 
the interval to which the present syndrome has been as­
signed. M utations in the PLP gene have been found in a 
number o f patients with Pelizaeus-M erzbacher disease
(PMD, MIM no. 312080), an X-linked disorder with dys- 
myelination of the cerebral white matter (Gencic et al. 
1989; Hudson et al. 1989; Trofatter et al. 1989), In addi­
tion, mutations in the PLP gene have been described in 
families with X-linked spastic paraplegia type 2 (SPG 2 ; 
MIM no. 312900; Saugier-Veber et al. 1994). SPG2 shares 
several clinical features with PMD including nystagmus, 
cerebellar ataxia and pyramidal syndrome, Dysmyelina- 
tion was also observed in one of the patients described 
here, but it was confined to the posterior columns o f  the 
spinal cord. Besides dysmyelination, symptoms com m on 
to the present syndrome and PMD/SPG2 are mental retar­
dation, hypotonia, nystagmus, optic atrophy and abnormal 
brainstem and somatosensory evoked potentials. The pre­
sent syndrome and PM D/SPG2 differ with respect to pe­
ripheral nerve involvement, hearing defect and the recur­
rent infections that occur only in the present X-linked 
mental retardation syndrome, whereas pyramidal and ex- 
trapyramidal signs, microcephaly and laryngeal stridor, 
which are characteristics of PMD/SPG2, are not observed. 
Despite these differences, the common symptoms suggest 
that PLP is a candidate gene for the present syndrome.
To screen the PLP gene for the presence of a mutation 
we directly sequenced the seven exons of the PLP gene of 
one of the patients (Diehl et al, 1986). No indications for 
mutations in the translated regions of the PLP gene were 
detected. However, a mutation might be present in the 
regulatory sequences, which were not analyzed, PM D- 
like clinical features have also been described in a patient 
with a duplication of the PLP gene (Cremers et al. 1987; 
cf. Ellis and Malcolm 1994). To rule out the possibility 
that in our family too, the disorder is due to gene duplica­
tion, the copy number of the PLP gene was tested in two 
patients. Hereby we excluded that the present syndrom e is 
due to amplification of the PLP gene in the affected males.
The syndrome described in this study resembles the X- 
linked mental retardation with aphasia described by W il­
son et al. (1992), Linkage analysis in the family with the 
latter disorder does not exclude the region between 
DXS1231 and DXS1001. Patients suffer from hypotonia 
and frequent infections especially of the respiratory tract, 
which is also typical of the present mental retardation syn­
drome. Furthermore, delayed myelination was shown by 
MRI scanning of one of the patients. This overlap in 
symptoms might indicate allelism of both disorders or 
they might be contiguous gene syndromes. O f the other 
X-linked mental retardation conditions that have been as­
signed to a region overlapping with that o f  the present dis­
order (see Neri 1994), there is some clinical resemblance 
with the Mohr-Tranebjaerg syndrome (MIM no. 304700, 
Tranebjaerg et al. 1995) regarding ataxia, psychomotor 
development, deafness and visual impairment, A  m ore de­
tailed mapping and, eventually, candidate gene analysis is 
necessary to give insight into the question of the allelism 
or overlap of genes involved in the described syndromes. 
Clinically, the present condition has most features in com ­
mon with the infantile X-linked ataxia and deafness syn­
drome described by Schmidley et al. (1987; M IM  no. 
301790). However, since the latter condition has not been
5 1 6
T a b le  1 Two-point lod scores 
o f  the markers tested Marker Locus LOD scores for 6  =
0.0 0.1 0.2 0.3 0.4
KAL Xp22.32 —CO -0.36 0,07 0.13 0.07
DXS443 Xp22.13 —OQ 0.70 0.77 0.57 0.29
DXS451 Xp22.13 —OO - 2.20 -0.98 -0.44 -0.16
DMD X p2l.:-p  21.1 —OO -2.47 -1.05 -0.42 - 0 . 11
DXS538 X pll.3 —OO -0.69 - 0.01 0.17 0.16
DXS7 Xpl 1.4-pl 1.3 —OO - 1.01 -0.50 -0.26 - 0 . 11
ALAS 2 Xpl 1.21 —OO -0.13 0.51 0.58 0.38
PGK1P1 Xql2 —GO -1.28 -0.37 -0.07 0.00
DXS339 Xql2 —OO -0.03 0.27 0.29 0.18
DXS559 X ql3 .1 —OQ - 1.22 -0,47 -0.19 -0.05»
DXS441 Xql3.2-ql3.3 —CO -0.58 0.30 0.38 0.19
CHM Xq21.2 —OQ -0.63 0.11 0.21 0.09
DXS1002 Xq21.2-q21.31 —OQ 0.55 0.69 0.47 0.18
DXS3 Xq21.33 -DO 0.89 0.87 0.48 0.09
DXS 454 Xq2L33 ■ -OO 2.84 2.23 1.45 0.61
DXS 1231 Xq21.33~q22.1 __oo - 1.00 -0.33 -0.06 0.03
DXS 178 Xq22.1 3.69 2.98 2.26 1.53 0.78
DXS 1106 Xq22.2 6.97 5.57 4.08 2.53 1.06
DXS 1105 Xq22.3 6.84 5.45 3.94 2.35 0.85
COL4A5 Xq22.3 5.38 4.18 2.95 1.78 0.76
DXS456 Xq22.3-q23 5.77 4.36 2.96 1.73 0.70
DXS424 Xq23 4.23 3.57 4.24 1.99 1.05
DXS 1001 Xq24 ■■ OO 2.01 1.97 1.47 0.76
DXS425 Xq26-q27.1 —OO 3.13 2.68 1.96 1.05
HPRT Xq26.1 —OO 0.70 0.81 0.54 0.19
DXS984 Xq27.1 —OO -0.23 0.40 0.47 0.30
DXS548 Xq27.3 0.48 0.36 0.25 0.16 0.07
FraXA Xq27.3 —OO 1.05 1.01 0.71 0.33
F8 Xq28 —OO -2.32 -0.97 -0.39 -0.13
DXS 1108 Xq28 —CO -2.96 - 1.68 -0.94 -0.40
assigned to a specific region of the X  chromosome, no 
conclusions can be drawn concerning allelism or overlap 
of a gene (or genes) involved in both syndromes.
D esp ite  our inability to find m utations or duplica- 
tions of the  PLP gene, a role o f this gene in the etiology 
o f the syndrom e we studied cannot be ru led  out until 
analysis o f  the regulatory sequences o f  the gene in pa­
tients w ith  the present syndrom e has been com pleted. 
E xclusion  of allelism  of the p resen t syndrom e and 
those resem bling it clinically aw aits further m apping  
studies.
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